An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to characterize the pharmacokinetics and
pharmacodynamics of hydromorphone oral solution in pediatric subjects aged 28 days to 16
years inclusive. The secondary objectives are to characterize the safety and efficacy of
hydromorphone oral solution in pediatric subjects aged 28 days to 16 years inclusive.